Abstract: Interleukin-8 (IL-8) is a kind of chemokine that plays an important role in the development and progression of many human malignancies. Previous studies have uncovered that polymorphisms in IL-8 is associated with the risk of many cancer types, but the results were inconsistent and inconclusive. In the present study, we aimed to explore the roles of IL-8 polymorphisms (rs2227307, rs2227306, +678T/C, rs1126647, and +1633C/T) and cancer risk through a systematic review and meta-analysis. Potential source of heterogeneity was sought out through sensitivity analysis. Desirable data were extracted and registered into databases. Finally, a total of ten publications comprising of 22 case-control studies, including 4,259 cases and 7,006 controls were ultimately eligible for the meta-analysis. No significant association was uncovered for all the five polymorphisms and the overall cancer risk. However, in the stratification analysis by cancer type, a significantly decreased risk of hepatocellular carcinoma was identified for rs2227306 polymorphism (T vs C: odds ratio [OR] =0.721, 95% confidence interval [CI] =0.567-0.916, P z =0.007; TT vs CC: OR =0.447, 95% CI =0.274-0.728, P z =0.001; TT vs TC + CC: OR =0.480, 95% CI =0.304-0.760, P z =0.002). In conclusion, our data shows that rs2227306 polymorphism plays a protective role in hepatocellular carcinoma risk. Future well-designed studies with a larger sample size are warranted to verify our findings.
Introduction
Interleukin-8 (IL-8) is a member of the CXC chemokine superfamily, which can activate neutrophil and lymphocyte attraction and cause a wide range of proinflammatory chemical reactions, generally by initiating and amplifying the acute inflammatory effects and chronic inflammatory process. 1, 2 It is also reported that IL-8 is related to different malignancies due to the involvement of thrombophilia and angiogenesis. [3] [4] [5] Increased secretion of IL-8 may contribute to the metastatic ability of hepatocellular carcinoma (HCC), 6 gastric cancer, 7 renal cell carcinoma, 8 colorectal cancer, 9 prostate cancer, 10 melanoma, 11 and bladder neoplasms. 12 These observations indicated that IL-8 might act as a biomarker for monitoring the clinical course of many tumor types.
The interleukin production is regulated by the polymorphisms of cytokine genes in promoter regions. 13 Thus, IL-8 is located on chromosome 4q13-21 and contains three introns, four exons, and a proximal promoter region.
14 Five polymorphisms in IL-8, +781C/T (rs2227306), +678T/C, 276A/T (rs1126647), +1633C/T, and +396G/T (rs2227307), have been extensively studied. 15 The +781C/T polymorphism is situated in an intron and acts as an important factor in the process of gene transcription and regulation. 16 The +678T/C polymorphism is associated with Behcet's disease submit your manuscript | www.dovepress.com
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Zhang et al and ulcerative colitis risk although it does not regulate the transcript of IL-8. 17, 18 A large number of investigations were conducted to explore the associations between IL-8 polymorphisms and risk of human cancers; however, the conclusions were inconsistent. [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] Therefore, it is necessary to perform a systematic review and meta-analysis to summarize the current available studies in order to draw a more cohesive conclusion.
Materials and methods search strategy
A systematic retrieval was performed to identify all eligible studies regarding IL-8 polymorphisms and cancer risk in PubMed, Web of Science, and Embase databases up until August 1, 2015 . The combination of search terms were presented as follows: ("IL8" OR "Interleukin 8" OR "IL-8") AND ("polymorphism" OR "variant" OR "SNP" OR "mutation" OR "genotype") AND ("tumor" OR "carcinoma" OR "cancer"). The language of the enrolled studies was restricted to English or Chinese. We also conducted a hand search of the reference lists of the enrolled studies or reviews to identify additional eligible studies.
study selection
Studies concerning the association of IL-8 polymorphisms with cancer risk were included if the following conditions were met: 1) any study described the association between IL-8 polymorphisms and cancer risk; 2) studies were casecontrol or cohort type; 3) the genotype frequencies of the cases and controls were available; and 4) each enrolled study should comprise at least one of rs2227306, rs2227307, rs1126647, +678T/C, and +1633C/T polymorphisms. Studies were excluded if: 1) there were no data regarding the associations between IL-8 polymorphisms and cancer risk; 2) they were duplicate of previous publications (when the same cohort was used in several publications, only the most complete information was included after careful examination); and 3) they were reviews or abstracts.
Data extraction
The following data from each article were extracted by MZ and TF independently: name of first author, year of publication, ethnicity of the participants (categorized as Caucasians, Asians, etc), source of control, number of controls and cases, genotyping method, and so on. We extracted the data through the following ways: 1) from the articles directly; 2) from the supplementary materials; and 3) by requesting the author through email to send the data.
statistical analysis
All the statistical analyses were performed using STATA 12.0 statistical software (StataCorp LP., College Station, TX, USA). A χ 2 -based Q-test assessed the heterogeneity in each research. If P,0.05, it indicated significant heterogeneity, the randomeffects model was adopted to estimate the pooled odds ratio (OR); 29 otherwise, the fixed-effects model was performed. 30 Two-sided P,0.05 were considered statistically significant. The χ 2 OR and 95% confidence interval (CI) were applied to evaluate the power of associations between IL-8 gene polymorphisms and cancer risk. Sensitivity analysis was also performed by removing one study at a time to calculate the overall homogeneity and effect size. Publication biases were calculated through Egger's regression test and Begg's funnel plot.
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Results
Identification and characteristics of the included studies
As presented in Figure 1 , the systematic literature retrieval identified a total of 574 relevant publications on PubMed, Web of Science, and Embase databases. After the titles and abstracts were checked only 31 articles related to the association between IL-8 polymorphisms and cancer risk remained. An additional 21 publications were excluded due to the lack of sufficient data, or they were without control groups, or they were related to the survival or treatment. As a result, ten publications comprising of 22 case-control studies were included in the present meta-analysis.
The characteristics of the enrolled studies were presented in Table 1 . Approximately 14 studies were conducted among Asian descendants 19, 20, [23] [24] [25] [26] and eight studies among Caucasians. 21, 22, 27, 28 In addition, there were eleven studies conducted by polymerase chain reaction-restriction fragment length polymorphism, [19] [20] [21] 24 four performed by TaqMan, 27, 28 and only one used polymerase chain reaction-sequence-specific primer. 25 The control groups were composed of ten population-based studies 22, 23, 25, 27, 28 and twelve hospital-based studies. [19] [20] [21] 24, 26 Approximately 19 of them were conformed with Hardy-Weinberg equilibrium, 19, 20, [23] [24] [25] [26] [27] whereas three others were not. 21, 22, 28 Furthermore, of these included studies, six studies 23, 27, 28 reported about gastric cancer and five about HCC. 19, 24 Oral cancer 20 and ovarian cancer 21 were described by three studies. Table 2 demonstrated the results of meta-analysis. No significant association was identified between the five polymorphisms in IL-8 (rs2227306, rs2227307, +678T/C, rs1126647, and +1633C/T) and the overall cancer risk. , P value of Q test for heterogeneity test; Pcr, polymerase chain reaction; Pcr-rFlP, polymerase chain reaction-restriction fragment length polymorphism; P z , P value of Z test for significance test; hB, hospital-based; PB, population-based.
Meta-analysis
95% CI =0.567-0.916, P z =0.007, Figure 2A ; TT vs CC: OR =0.447, 95% CI =0.274-0.728, P z =0.001, Figure 2B ; TT vs TC + CC: OR =0.480, 95% CI =0.304-0.760, P z =0.002, Figure 2C ), whereas no evidence showed significant relevance between the IL-8 rs2227306 polymorphism and gastric cancer that rs2227306 polymorphism in IL-8 had no significant association with cancer risk in the subgroup analyses sorted by either genotyping method or ethnicity. However, as for the subgroup analysis categorized by cancer type, it demonstrated a decreased risk of HCC (T vs C: OR =0.721, submit your manuscript | www.dovepress.com
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sensitivity analysis and publication bias
By deleting one study at a time to evaluate the influence of an individual study on synthetic statistics, we referred this method as a sensitivity analysis. As presented in Figure 3 , although each study was removed, the overall results did not alter obviously, which indicated the stability of our eligible statistics. In addition, all the enrolled articles were examined by using Begg's funnel plot and Egger's test in order to find whether publication bias existed, and as shown in Figure 4 , no obvious biases were identified. In addition, the study quality was assessed by Newcastle-Ottawa Scale 33 (Table 3) .
Discussion
IL-8 is a kind of chemokine, which has a significant role in tumorigenesis process, particularly for tumor growth, invasion, and angiogenesis. 34 Growing evidence has suggested that abnormal expression of IL-8 may lead to several tumor types, including prostate, breast, lung, and liver cancers. 6, 10, 11 To illustrate the complicated process of tumorigenesis and improve the theory for preventive interventions, main genes associated with cancer risk should be explored. 35 Genotypingrelated polymorphisms were regarded as eligible and valuable methods in predicting cancer risk and prognosis.
The IL-8 gene, located on chromosome 4q12-21, is 5.2-kb long and is made up of four exons and three introns. A total of five polymorphisms in IL-8 were reported, such as rs4073, rs2227307, rs2227306, +678T/C, rs1126647, and +1633C/T. 19, 20, [22] [23] [24] [25] [26] [27] However, only rs4073 and rs2227306 polymorphisms are related to the expression alteration of IL-8. 36, 37 Rs4073 polymorphism is located at the promoter region of IL-8, and a rare allele A of this polymorphism has been identified, which contributed to an increased level of IL-8. 38 In addition, previous studies have confirmed that A allele is associated with an increased risk of many cancer types. 19, 20, 39 Recently, several meta-analysis have been conducted and have identified that rs4073 polymorphism was related to an increased risk of overall cancers and potentially submit your manuscript | www.dovepress.com
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Zhang et al offered an evidence-based medical certificate to investigate cancer risk. 35, 40, 41 Considering that a large number of metaanalyses concentrated on IL-8 rs4073 polymorphism and cancer risk were performed, we focus only on several other polymorphisms in IL-8 and cancer risk. Rs2227306 polymorphism is located at an intron region of IL-8 and is involved in the promotion of gene transcription and regulation, 42 while the best strengthening influence on IL-8 expression was the common haplotype rs4073-rs2227306. 36 Although several other polymorphisms do not influence the expression of IL-8, many studies have confirmed the association of those polymorphisms with cancer risk. Wang et al 19 identified that no association of rs4073, rs2227306, -353A/T, and +678T/C polymorphisms in IL-8 gene and HCC risk was revealed in the Chinese population. Then, Wang et al 39 Currently, the relationship between IL-8 polymorphisms and cancer risk has been widely reported, but the conclusions remained controversial. Meta-analysis has been regarded as a crucial method to evaluate the influence of chosen genetic polymorphisms on cancer risk. To the very best of our knowledge, this is the first comprehensive meta-analysis of genetics studies on the relevance between IL-8 gene polymorphisms and cancer risk. We indicated a significantly decreased risk of HCC for rs2227306 polymorphism in allele contrast, recessive, and homozygous models.
Limitations
Although we have conducted a general retrieval for all eligible studies, there are several drawbacks that should be mentioned. First, the results may lack statistical power because of the limited sample size and limited number of studies enrolled. Second, only publications indexed in PubMed, Web of Science, and Embase databases were retrieved, while some relevant studies might have been ignored in other databases. Finally, unadjusted estimates were obtained in this work, and a more accurate analysis should be conducted on the basis of specific details such as sex, age, alcohol status, and environmental conditions.
Conclusion
Our meta-analysis suggests that there is no significant relationship between polymorphisms in IL-8 (rs2227307, rs2227306, +678T/C, rs1126647, and +1633C/T) and overall cancer risk. However, in the subgroup analysis by cancer type, a decreased risk of HCC was found for rs2227306 polymorphism. Well-designed studies are needed to further explicit the actual relevance between IL-8 polymorphisms and cancer risk.
